Trials / Sponsors / Hangzhou Cancer Hospital
Hangzhou Cancer Hospital
Academic / Other · 10 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer Esophageal Neoplasm, Esophageal Diseases, Esophageal Squamous Cell Carcinoma | Phase 2 | 2020-10-01 |
| Unknown | Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells Advanced Cancer, ADCC, NK Cell Mediated Immunity | Phase 1 | 2018-08-01 |
| Unknown | Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma Esophageal Neoplasms, Esophageal Diseases | Phase 2 | 2017-08-10 |
| Completed | Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer Esophageal Neoplasms, Esophageal Diseases, Esophageal Squamous Cell Carcinoma | Phase 2 | 2017-06-14 |
| Completed | PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer Esophageal Cancer | N/A | 2017-03-14 |
| Unknown | SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer Esophageal Cancer, Metastatic Esophageal Cancer, Stereotactic Body Radiation Therapy | Phase 2 | 2016-01-01 |
| Unknown | Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients. Esophageal Cancer, Endostatin | Phase 2 | 2016-01-01 |
| Unknown | Apatinib for Metastatic Esophageal Cancer. Esophageal Cancer, Metastatic Esophageal Cancer, Apatinib | Phase 2 | 2015-09-01 |
| Unknown | RT Plus EGFR-TKI for Wild-type NSCLC Non-small Cell Lung Cancer, Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) | Phase 2 | 2012-01-01 |
| Completed | CCRT for Esophageal Cancer. Esophageal Cancer, Concurrent Chemoradiotherapy, Oxaliplatin | Phase 2 | 2005-01-01 |